The lobby of the pharmaceutical companies is not satisfied from the US decision to support the proposal of the World Health Organization on the abolition of intellectual property in Covid-19 vaccines.
The International Federation of Pharmaceutical Industries (IFPMA) described the decision as “disappointing”.
“We are fully aligned with the goal of distributing Covid-19 vaccines quickly and fairly around the world. But as we continue to say, a temporary lifting is the common but wrong answer to a complex problem “, underlined the announcement of the pharmacy lobby, which is based in Geneva, as broadcast by AMPE.
“The removal of patents on vaccines for Covid-19 will not increase production, nor will it provide the practical solutions needed to deal with this global health crisis. “On the contrary, it will probably lead to disharmony,” IFPMA added.
The real challenges are trade barriers, supply chain congestion, shortages of raw materials and “the willingness of rich countries to start sharing doses with poor countries,” he said.
The president Joe Biden, who had advocated for the removal of patents during his election campaign, said yesterday that he supported the WHO proposal to abolish intellectual property in vaccines for coronavirus.
The Organization in turn spoke of a “monumental moment”.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
